Diabetic Retinopathy Overview
Diabetic Retinopathy Stages
(Source: A proposal for early and personalized treatment of diabetic retinopathy based on
clinical pathophysiology and molecular phenotyping, Vision Research, 2017)
Mechanism of Action
Source: Institute for Basic Science, Center for Vascular Research
EG-Mirotin Highlights
In-vivo Proof-of-Concept
OIR mice model
conducted in-house
STZ - induced diabetic rat model
conducted at Comparative BioScience, US
Clinical Trial Status
Preclinical efficacy
test complete
2012
Safety pharmacology
tests complete
2012
EMA Phase 1
approval (EU)
2012
Phase 1
Complete (EU)
2014
EMA Phase 2a
approval (EU)
2014
EMA Phase 2a
Completed (EU)
2020.02
MFDS Phase 2
approval (KOR)
2020.03
MFDS Phase 2
Completed (KOR)
2021.07